A comprehensive analysis integrating copy number variations, gene expression, clinicopathological features, and patient survival data for 41 TDRD genes in breast cancer revealed that PHF20L1 was the most prominently amplified TDRD gene in TCGA breast cancer samples. This evidence concerns the gene PHF20L1 and breast cancer.